Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multi-dimensional QSAR in drug discovery.

Markus A Lill1

  • 1Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN 47907, USA. mlill@purdue.edu

Drug Discovery Today
|December 7, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

New Analogs of the Compstatin Family of Clinical Complement Inhibitors with Low Picomolar Target Affinity.

Journal of medicinal chemistry·2026
Same author

ModelCIF Update: Supporting Emerging Classes of Computational Macromolecular Models.

Journal of molecular biology·2026
Same author

Investigating whether deep learning models for co-folding learn the physics of protein-ligand interactions.

Nature communications·2025
Same author

Neural SHAKE: geometric constraints in neural differential equations.

Journal of cheminformatics·2025
Same author

Accelerated Hydration Site Localization and Thermodynamic Profiling.

Journal of chemical information and modeling·2025
Same author

Biosynthesis of the bacterial antibiotic 3,7-dihydroxytropolone through enzymatic salvaging of catabolic shunt products.

Chemical science·2024
Same journal

IdopNetworks: How to infer the individualized genetic architecture of genomics for precision medicine.

Drug discovery today·2026
Same journal

Organoid-AI platforms need integrated governance in drug discovery.

Drug discovery today·2026
Same journal

Inorganic nanoparticles for diagnostics, drug delivery and therapy for solid tumors.

Drug discovery today·2026
Same journal

HDAC11 as a potential therapeutic target for Alzheimer's disease.

Drug discovery today·2026
Same journal

From biologics to small-molecule modulators: The evolving landscape of interleukin-targeted therapeutics.

Drug discovery today·2026
Same journal

Targeting the GLP-1 receptor pathways for dual management of obesity and depression.

Drug discovery today·2026
See all related articles

Quantitative structure-activity relationship (QSAR) models predict molecular properties. This review explores advanced QSAR methods incorporating protein flexibility and solvation for improved drug discovery.

Area of Science:

  • Computational chemistry and cheminformatics
  • Drug discovery and medicinal chemistry

Background:

  • Quantitative structure-activity relationships (QSAR) are computational models predicting molecular properties like binding affinity and toxicity.
  • Traditional QSAR often overlooks the target protein's role, focusing solely on ligand properties.
  • Experimental data highlight the crucial involvement of target proteins in molecular binding processes.

Purpose of the Study:

  • To review recent advancements in QSAR that incorporate higher-dimensional aspects.
  • To discuss the benefits of these advanced QSAR concepts for accelerating drug discovery.
  • To highlight methods simulating induced fit, alternative binding modes, and solvation.

Main Methods:

  • Exploration of QSAR models simulating induced fit.

Related Experiment Videos

  • Analysis of methods for simultaneous exploration of alternative binding modes.
  • Review of QSAR approaches incorporating solvation scenarios.

    • Main Results:

    • Advanced QSAR models offer a more comprehensive understanding of molecular interactions.
    • Incorporating protein flexibility and solvation enhances prediction accuracy.
    • These methods provide deeper insights into ligand-target binding dynamics.

    Conclusions:

    • Recent QSAR concepts expanding beyond ligand properties are crucial for modern drug discovery.
    • Simulating induced fit, diverse binding modes, and solvation significantly benefits drug design.
    • These advanced computational approaches promise more effective and efficient drug development pipelines.